Mugneret F, Solary E, Favre B, Caillot D, Sidaner I, Guy H
Laboratoire d'Histologie et de Cytogénétique, Faculté de Médecine, Dijon, France.
Cancer Genet Cytogenet. 1992 May;60(1):90-2. doi: 10.1016/0165-4608(92)90241-y.
A new case of t(3;17)(q26;q22) was observed in a Philadelphia-positive (Ph+) chronic myelogenous leukemia in acceleration 1 month before occurrence of the blastic phase. Abnormal megakaryocytopoiesis and thrombopenia were noted, but blast cells did not express platelet markers. The same translocation was previously reported in three myeloproliferative disorders in acceleration or in the process of becoming acute. Translocations or inversions of chromosome 3 with breakpoint involving the band 3q26 were specifically associated with megakaryoblastic acute phase or abnormal megakaryocytopoiesis. This report confirms that the t(3;17)(q26;q22) is a specific nonrandom chromosomal abnormality associated with the acute nonlymphoblastic phase of myeloproliferative disorders and megakaryocytopoiesis dysfunction.
在费城染色体阳性(Ph+)的慢性髓性白血病加速期,于急变期出现前1个月观察到1例新的t(3;17)(q26;q22)病例。观察到异常巨核细胞生成和血小板减少,但原始细胞不表达血小板标志物。先前在3例处于加速期或正在转变为急性的骨髓增殖性疾病中报道过相同的易位。3号染色体的易位或倒位,其断点涉及3q26带,与巨核母细胞急性期或异常巨核细胞生成特别相关。本报告证实,t(3;17)(q26;q22)是一种与骨髓增殖性疾病的急性非淋巴细胞期和巨核细胞生成功能障碍相关的特定非随机染色体异常。